Search - tctmd.com

Displaying 661 - 680 of 1898

Sort: Relevancy | Date

News Daily News

Meta-analysis Confirms Late Safety of Second-Generation DES

L.A. McKeown

June 10, 2015

News Daily News

Los Índices de Episodios suelen estar Sobrevalorados en los Ensayos Cardiovasculares

Yael L. Maxwell

June 10, 2015

News Industry News

Interventional Cardiovascular Device Development: Considerations in Clinical Trial Implementation

June 10, 2015

News Daily News

Event Rates Often Overestimated in Cardiovascular Trials

Yael L. Maxwell

June 10, 2015

News Daily News

Bivalirudin Plus GPI Cuts Bleeding, Mortality in Heart Failure Patients Undergoing PCI

June 09, 2015

Presentation TVT 2015

Insights From the US TVT Registry

Presenter: John D. Carroll

June 05, 2015

Presentation TVT 2015

NOTION in All-Comers

Presenter: Lars Sondergaard

June 05, 2015

Presentation TVT 2015

CoreValve US 2-Year Follow-up

Presenter: Michael J. Reardon

June 05, 2015

Presentation TVT 2015

PARTNER 5-Year Follow-up

Presenter: Martin B. Leon

June 05, 2015

Presentation TVT 2015

Bicuspid Aortic Valve Disease

Presenter: Mathew Williams

June 05, 2015

Presentation TVT 2015

GARY

Presenter: Helge Möllmann

June 05, 2015

Presentation TVT 2015

FRANCE 2

Presenter: Helene Eltchaninoff

June 05, 2015

Presentation TVT 2015

UK Registry

Presenter: Neil E. Moat

June 05, 2015

Presentation TVT 2015

ADVANCE

Presenter: Nicolo Piazza

June 05, 2015

News Daily News

IMPROVE-IT Published: Hotly Debated Ezetimibe Helpful When Added to Statin Therapy

Yael L. Maxwell

June 05, 2015

News Industry News

Amgen Completes Enrollment In Large Cardiovascular Outcomes Trial Of Repatha™ (Evolocumab) In Patients With High Cholesterol And Clinically Evident Cardiovascular Disease

June 05, 2015

News Daily News

Ticagrelor Pretreatment May Help Protect Against Periprocedural Myonecrosis in NSTE-ACS

June 04, 2015

News Industry News

First patient enrolled in Pivotal's POMEGA Phase IIa clinical trial with PVT-100

June 04, 2015

News Daily News

ISAR-DESIRE 3: Drug-Coated Balloon Shows Durable Antirestenotic Effect in DES Restenosis

L.A. McKeown

June 03, 2015

News Daily News

Belgian Registry Reports Similar 3-Year Survival for Sapien, CoreValve in Transfemoral TAVR

Yael L. Maxwell

June 03, 2015

Advertisement

Meta-analysis Confirms Late Safety of Second-Generation DES

Los Índices de Episodios suelen estar Sobrevalorados en los Ensayos Cardiovasculares

Interventional Cardiovascular Device Development: Considerations in Clinical Trial Implementation

Event Rates Often Overestimated in Cardiovascular Trials

Bivalirudin Plus GPI Cuts Bleeding, Mortality in Heart Failure Patients Undergoing PCI

Insights From the US TVT Registry

NOTION in All-Comers

CoreValve US 2-Year Follow-up

PARTNER 5-Year Follow-up

Bicuspid Aortic Valve Disease

GARY

FRANCE 2

UK Registry

ADVANCE

IMPROVE-IT Published: Hotly Debated Ezetimibe Helpful When Added to Statin Therapy

Amgen Completes Enrollment In Large Cardiovascular Outcomes Trial Of Repatha™ (Evolocumab) In Patients With High Cholesterol And Clinically Evident Cardiovascular Disease

Ticagrelor Pretreatment May Help Protect Against Periprocedural Myonecrosis in NSTE-ACS

First patient enrolled in Pivotal's POMEGA Phase IIa clinical trial with PVT-100

ISAR-DESIRE 3: Drug-Coated Balloon Shows Durable Antirestenotic Effect in DES Restenosis

Belgian Registry Reports Similar 3-Year Survival for Sapien, CoreValve in Transfemoral TAVR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content